Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

Journal of the American Academy of Dermatology
Alan MenterReva Bhushan

Abstract

Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin and joint manifestations affecting approximately 2% of the population. In this first of 5 sections of the guidelines of care for psoriasis, we discuss the classification of psoriasis; associated comorbidities including autoimmune diseases, cardiovascular risk, psychiatric/psychologic issues, and cancer risk; along with assessment tools for skin disease and quality-of-life issues. Finally, we will discuss the safety and efficacy of the biologic treatments used to treat patients with psoriasis.

References

Mar 24, 1990·BMJ : British Medical Journal·K PoikolainenP Kärkkäinen
Jul 1, 1988·Journal of the American Academy of Dermatology·H H RoenigkG D Weinstein
May 1, 1994·Clinical and Experimental Dermatology·A Y Finlay, G K Khan
Apr 1, 1994·The British Journal of Dermatology·K PoikolainenJ Karvonen
Sep 1, 1993·Journal of the American Academy of Dermatology·D L DuffyN G Martin
Jan 1, 1996·The British Journal of Dermatology·L NaldiT Cainelli
Jul 27, 1999·The British Journal of Dermatology·B LindelöfL Emtestam
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Sep 1, 1999·Rheumatic Diseases Clinics of North America·R K Avery
May 3, 2000·The British Journal of Dermatology·B KirbyC E Griffiths
May 29, 2000·Brain : a Journal of Neurology·S A BroadleyD A Compston
Aug 18, 2000·Immunology and Cell Biology·B M Saunders, A M Cooper
May 1, 2001·Cleveland Clinic Journal of Medicine·R K Avery
Jul 28, 2001·The New England Journal of Medicine·C N EllisUNKNOWN Alefacept Clinical Study Group
Nov 28, 2001·Neurology·N L Sicotte, R R Voskuhl
Mar 12, 2002·The Journal of Investigative Dermatology·P BoffettaB Lindelöf
Nov 7, 2002·International Journal of Cardiology·Stefan D Anker, Andrew J S Coats
Mar 15, 2003·Rheumatic Diseases Clinics of North America·Barry Bresnihan, Gaye Cunnane
May 20, 2003·The British Journal of Dermatology·G G Krueger, C N Ellis
May 29, 2003·Dermatology : International Journal for Clinical and Investigative Dermatology·A Y FinlayUNKNOWN Alefacept Clinical Study Group
Jun 11, 2003·Journal of the European Academy of Dermatology and Venereology : JEADV·G G Krueger
Jul 15, 2003·Clinical Microbiology Reviews·Andrea DuchiniPaul J Pockros
Aug 6, 2003·Annals of Internal Medicine·Francesc VidalCristóbal Richart
Nov 25, 2003·The New England Journal of Medicine·Mark LebwohlUNKNOWN Efalizumab Study Group
Nov 25, 2003·The New England Journal of Medicine·Craig L LeonardiUNKNOWN Etanercept Psoriasis Study Group
Dec 12, 2003·European Journal of Haematology·John KuruvillaSheldon C Naiman
Dec 17, 2003·Archives of Dermatology·Alice B GottliebRalph Zitnik
Dec 18, 2003·JAMA : the Journal of the American Medical Association·Kenneth B GordonUNKNOWN Efalizumab Study Group
Feb 27, 2004·The American Journal of Medicine·Frederick Wolfe, Kaleb Michaud
Apr 8, 2004·Human Molecular Genetics·David A DymentUNKNOWN Canadian Collaborative Study Group
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Vera M HeydendaelMenno A de Rie
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·Robert S SternTara Rolstad
Apr 16, 2004·The Journal of Investigative Dermatology. Symposium Proceedings·John de KorteJan D Bos
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R S WallisD O Beenhouwer
Jul 15, 2004·The Australasian Journal of Dermatology·Paul A J RussoAlan J Cooper
Sep 24, 2004·Dermatologic Therapy·Toral Patel, Kenneth B Gordon

❮ Previous
Next ❯

Citations

Sep 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marina Papoutsaki, Antonio Costanzo
Sep 6, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Marina PapoutsakiAntonio Costanzo
May 10, 2011·Archives of Dermatological Research·Andreas KerstanA Trautmann
Feb 5, 2013·Archives of Dermatological Research·Melissa SerravalloNeil I Brody
Mar 16, 2012·Sleep & Breathing = Schlaf & Atmung·Semsettin KaracaMehmet Unlu
Apr 3, 2012·Chinese Journal of Integrative Medicine·Chuan-Jian LuJing-Wen Deng
Apr 3, 2012·Chinese Journal of Integrative Medicine·Mohammad Khurshid Azam Basra, Sadath Hussain
Jun 19, 2013·American Journal of Clinical Dermatology·Wolf-Henning Boehncke, Alan Menter
Apr 13, 2013·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Emily Yiping GanHong Liang Tey
Jun 30, 2009·Actas dermo-sifiliográficas·L PuigUNKNOWN Grupo Español de Psoriasis de la Academia Española de Dermatología y Venereología
Feb 3, 2009·Nature Clinical Practice. Rheumatology·Kristine E NogralesAnne M Bowcock
Sep 30, 2010·Nature Reviews. Rheumatology·Erwin F WagnerErwin Tschachler
Sep 14, 2011·Nature Reviews. Rheumatology·Caroline A ChangPaul F Lizzul
Nov 9, 2011·Nature Reviews. Rheumatology·Darren D O'Rielly, Proton Rahman
Feb 22, 2012·Rheumatology·Gabrielle H KingsleyDavid L Scott
Dec 5, 2012·Arthritis·Peter LloydAlan Menter
May 1, 2012·International Journal of Rheumatology·Shinji MaedaRyuzo Ueda
Jan 6, 2011·Arthritis Research & Therapy·Andrew Barr, Andrew Keat
Nov 30, 2013·Arthritis Research & Therapy·Helen BenhamHill Gaston
Jul 16, 2011·Clinical, Cosmetic and Investigational Dermatology·Elizabeth E Uhlenhake, David A Mehregan
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Thao U Nguyen, John Koo
Jan 1, 2009·Clinical, Cosmetic and Investigational Dermatology·Jennifer D BahnerNeil J Korman
Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Angela Y Moore, Blakely S Richardson
Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Melissa A Michelon, Alice B Gottlieb
Jan 1, 2010·Clinical, Cosmetic and Investigational Dermatology·Philip M Laws, Helen S Young
Aug 10, 2010·Core Evidence·Eliana Krulig, Kenneth B Gordon
Jan 27, 2011·Drug Design, Development and Therapy·Ignacio Garcia-ValladaresLuis R Espinoza
Apr 10, 2013·Drug Design, Development and Therapy·Andrew C PalfreemanFiona E McCann
Jun 23, 2009·Drugs·Anna L ChienCharles N Ellis
Apr 7, 2009·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Juliane Weber, Susan J Keam
Oct 15, 2009·American Journal of Clinical Dermatology·Steven R Feldman, Brad A Yentzer
Jul 1, 2010·American Journal of Clinical Dermatology·Srdjan ProdanovichFrancisco Kerdel
Jul 1, 2010·American Journal of Clinical Dermatology·Mariya Miteva
Jul 1, 2010·American Journal of Clinical Dermatology·Franco RongiolettiAurora Parodi
Sep 4, 2012·Drugs·Philip M Laws, Helen S Young
Dec 23, 2010·Pharmacogenomics·Darren D O'Rielly, Proton Rahman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Cardiovascular Inflammation

Inflammation plays a significant role in the development of cardiovascular diseases, an understanding of these endogenous processes is critical for evaluating the risks and potential treatment strategies. Discover the latest research on cardiovascular inflammation here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.